Clinical and Pathological Characteristics of Hard Nodules Resistant to Morcellation During Holmium Laser Enucleation of the Prostate
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Purpose: To identify the clinical and pathological characteristics of hard nodules resistant to morcellation (HNRM) during holmium laser enucleation of the prostate (HoLEP) for benign prostatic hyperplasia (BPH). Methods: Between July 2008 and October 2011, 246 patients underwent HoLEP for symptomatic BPH. The first 30 patients were excluded from the analysis due to the learning curve of the procedure. The remaining patients were divided into HNRM (n=29) and non-HNRM groups (n=187), and comparative analysis of the clinical parameters of the two groups was performed. International prostate symptom score analysis and urodynamic studies were performed preoperatively. Histological analysis was performed after hematoxylin and eosin staining and Masson trichrome staining of the HNRM specimens. Results: Twenty-nine patients (13.4%) had HNRM. The patients in the HNRM group had significantly higher proportions of advanced age (≥65 years, P=0.029), total prostate volume ≥65 mL (P<0.001), transition zone volume ≥35 mL (P<0.001), serum prostate-specific antigen levels ≥10 ng/mL (P=0.007), and functional urethral length ≥70 mm (P=0.009); larger enucleation weight (P<0.001); longer operation (P=0.001), enucleation (P=0.042), and morcellation times (P<0.001); and higher enucleation ratio (P=0.028) and enucleation efficacy (P=0.001). After adjusting for confounding factors, multivariate logistic regression analysis revealed that age ≥65 years and total prostate volume ≥65 mL were independent risk factors for HNRM. Pathological examination did not reveal any malignant cells, with mainly dense fibrous tissue found in the HNRM. Conclusions: HNRM can make morcellation cumbersome and time-consuming, and older patients with larger prostates have a higher incidence of HNRM. However, the histopathology of HNRM revealed mainly fibrotic tissue.
Abstract
Purpose: To identify the clinical and pathological characteristics of hard nodules resistant to morcellation (HNRM) during holmium laser enucleation of the prostate (HoLEP) for benign prostatic hyperplasia (BPH). Methods: Between July 2008 and October 2011, 246 patients underwent HoLEP for symptomatic BPH. The first 30 patients were excluded from the analysis due to the learning curve of the procedure. The remaining patients were divided into HNRM (n=29) and non-HNRM groups (n=187), and comparative analysis of the clinical parameters of the two groups was performed. International prostate symptom score analysis and urodynamic studies were performed preoperatively. Histological analysis was performed after hematoxylin and eosin staining and Masson trichrome staining of the HNRM specimens. Results: Twenty-nine patients (13.4%) had HNRM. The patients in the HNRM group had significantly higher proportions of advanced age (≥65 years, P=0.029), total prostate volume ≥65 mL (P<0.001), transition zone volume ≥35 mL (P<0.001), serum prostate-specific antigen levels ≥10 ng/mL (P=0.007), and functional urethral length ≥70 mm (P=0.009); larger enucleation weight (P<0.001); longer operation (P=0.001), enucleation (P=0.042), and morcellation times (P<0.001); and higher enucleation ratio (P=0.028) and enucleation efficacy (P=0.001). After adjusting for confounding factors, multivariate logistic regression analysis revealed that age ≥65 years and total prostate volume ≥65 mL were independent risk factors for HNRM. Pathological examination did not reveal any malignant cells, with mainly dense fibrous tissue found in the HNRM. Conclusions: HNRM can make morcellation cumbersome and time-consuming, and older patients with larger prostates have a higher incidence of HNRM. However, the histopathology of HNRM revealed mainly fibrotic tissue.
참고문헌 (26)
- Gilling PJ, "Holmium laser resection of the prostate: preliminary results of a new method for the treatment of benign prostatic hyperplasia", Urology, 47, pp.48~51 (1996)
- 김명, "Technical Aspects of Holmium Laser Enucleation of the Prostate for Benign Prostatic Hyperplasia", Investigative and Clinical Urology, 54(9), pp.570~579 (2013), 대한비뇨기과학회
- Kuo RL, "Holmium laser enucleation of the prostate (HoLEP): a technical update", World J Surg Oncol, 1, pp.6~ (2003)
- Hettiarachchi JA, "Holmium laser enucleation for large (greater than 100 mL) prostate glands", Int J Urol, 9, pp.233~236 (2002)
- Fraundorfer MR, "Holmium:YAG laser enucleation of the prostate combined with mechanical morcellation: preliminary results", Eur Urol, 33, pp.69~72 (1998)
- Elzayat EA, "Holmium laser enucleation of the prostate: a size-independent new gold standard", Urology, 66(5 Suppl), pp.108~113 (2005)
- Vavassori I, "Three-year outcome following holmium laser enucleation of the prostate combined with mechanical morcellation in 330 consecutive patients", Eur Urol, 53, pp.599~604 (2008)
- Ritter M, "Standardized comparison of prostate morcellators using a new ex-vivo model", J Endourol, 26, pp.697~700 (2012)
- El-Hakim A, "Holmium laser enucleation of the prostate can be taught: the first learning experience", BJU Int, 90, pp.863~869 (2002)
- 배정범, "The Learning Curve for Holmium Laser Enucleation of the Prostate: A Single-Center Experience", Investigative and Clinical Urology, 51(10), pp.688~693 (2010), 대한비뇨기과학회
- Griffiths D, "Standardization of terminology of lower urinary tract function: pressure-flow studies of voiding, urethral resistance, and urethral obstruction. International Continence Society Subcommittee on Standardization of Terminology of Pressure-Flow Studies", Neurourol Urodyn, 16, pp.1~18 (1997)
- Nitti VW, "Pressure flow urodynamic studies: the gold standard for diagnosing bladder outlet obstruction", Rev Urol, 7(Suppl 6), pp.S14~S21 (2005)
- Barry MJ, "The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association", J Urol, 148, pp.1549~1557 (1992)
- Jeong CW, "Enucleation ratio efficacy might be a better predictor to assess learning curve of holmium laser enucleation of the prostate", Int Braz J Urol, 38, pp.362~371 (2012)
- Dindo D, "Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey", Ann Surg, 240, pp.205~213 (2004)
- Tarcan T, "Age-related erectile and voiding dysfunction: the role of arterial insufficiency", Br J Urol, 82(Suppl 1), pp.26~33 (1998)
- Kozlowski R, "Chronic ischemia alters prostate structure and reactivity in rabbits", J Urol, 165, pp.1019~1026 (2001)
- Zarifpour M, "Protective effect of tadalafil on the functional and structural changes of the rat ventral prostate caused by chronic pelvic ischemia", Prostate, 75, pp.233~241 (2015)
- Bauman TM, "Characterization of fibrillar collagens and extracellular matrix of glandular benign prostatic hyperplasia nodules", PLoS One, 9, pp.e109102~ (2014)
- Berger AP, "Vascular resistance in the prostate evaluated by colour Doppler ultrasonography: is benign prostatic hyperplasia a vascular disease", BJU Int, 98, pp.587~590 (2006)
- Vesely S, "Relationship between age, prostate volume, prostate-specific antigen, symptom score and uroflowmetry in men with lower urinary tract symptoms", Scand J Urol Nephrol, 37, pp.322~328 (2003)
- Barry MJ, "Winfield HN. Relationship of symptoms of prostatism to commonly used physiological and anatomical measures of the severity of benign prostatic hyperplasia", J Urol, 150(2 Pt 1), pp.351~358 (1993)
- Ezz el Din K, "Correlation between uroflowmetry, prostate volume, postvoid residue, and lower urinary tract symptoms as measured by the International Prostate Symptom Score", Urology, 48, pp.393~397 (1996)
- van Venrooij GE, "The value of symptom score, quality of life score, maximal urinary flow rate, residual volume and prostate size for the diagnosis of obstructive benign prostatic hyperplasia: a urodynamic analysis", J Urol, 155, pp.2014~2018 (1996)
- Eckhardt MD, "Symptoms and quality of life versus age, prostate volume, and urodynamic parameters in 565 strictly selected men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia", Urology, 57, pp.695~700 (2001)
- Rosenzweig-Bublil N, "Stromal fibrosis reaction in rat prostates induced by alpha 1 adrenergic stimulation", J Androl, 27, pp.276~284 (2006)